Toshiba Corp. said Friday it has signed a licensing agreement with U.S. firm Antara BioSciences Inc. to transfer its expertise on compact, low-cost DNA chips and DNA diagnostic equipment.

Antara will use the deal to develop similar products it aims to sell under its own brand in the United States after obtaining approval from the U.S. Food and Drug Administration.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.